Navigation Links
Texas A&M Research Aids Military in Fighting Brucellosis on the Battlefield
Date:8/21/2013

College Station, TX (PRWEB) August 21, 2013

Researchers at Texas A&M Health Science Center (TAMHSC) are nearing completion of the first human Brucella vaccine aimed at combatting the Brucella bacteria that cause brucellosis, a chronic disease that causes high fever and incapacitation. If left untreated, the disease can induce neurological symptoms and cross the blood-brain barrier to inflict more damage.

Because Brucella is considered a select agent by the Centers for Disease Control and Prevention, meaning that it has been weaponized, the vaccine would be primarily used as a biodefense vaccine by the military. Allison Rice-Ficht, Ph.D., director of the Center for Microencapsulation and Drug Delivery at Texas A&M Health Science Center, and her team therefore have not only developed the vaccine but are also working on an improved delivery system to make the vaccine stable at room temperature and able to be taken orally. She calls it a “pocket vaccine,” and it will allow military personnel to carry capsules in their pockets for oral consumption in crisis situations.

To develop the vaccine’s military applications, Ficht received a $2.6 million grant in 2007 from the Department of Defense (DoD), specifically the U.S. Army Medical Research and Material Command. Since then the original grant has been renewed twice for a total of an additional $1.6 million. It will conclude this December.

“We are now addressing packaging issues so that the future ‘pocket vaccine’ will be able to be distributed at room temperature and without medical personnel,” she said.

After more than 18 months, a patent application is now pending on the vaccine. Vaccination studies in animal models are concluding, and Ficht hopes to have the vaccine in clinical human trials in the near future.

When the vaccine is ready for production, and through a joint effort between Texas A&M University, Texas A&M Health Science Center and other collaborators, INCELL Corporation in San Antonio will provide small-scale manufacturing for pilot studies. Large-scale manufacturing will be done by the National Center for Therapeutics Manufacturing (NCTM), the first multidisciplinary workforce education institution and biopharmaceutical manufacturing center, at Texas A&M University.

“We see this large-scale production as the future with NCTM,” said Ficht. “Such collaboration maximizes the resources of the Texas A&M System.”

Since that initial grant in 2007 Ficht has worked to leverage the DOD funding for additional aid, including a Gates Foundation grant for $100,000 in 2009 for a related research project. She will continue to contribute to ongoing projects with U.S. Army Medical Research Institute of Infectious Diseases for controlled release viral vaccines.

Since 1984, Ficht has been a faculty member of the TAMHSC College of Medicine in the Department of Molecular and Cellular Medicine. In addition to being named a Texas A&M Regents Professor in 2004, Ficht currently serves as Associate Vice President of Research for the Texas A&M Health Science Center.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11050830.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Cellucor to Attend Europa Get Fit & Sports Expo in Dallas, Texas
2. Texas A&M College of Nursing's New Nursing Program Answers Workforce Demand
3. TLU Professor Bill Squires Receives the 2013 Texas Health Champion Award
4. XL Protection Now Offering Dallas Texas Residents Professionally Installed Security Camera Video Surveillance Systems
5. DentalSpots.com Expands Network Capabilities to Help Fill Texas Dental Jobs
6. Dallas’ Park Cities Pet Sitter, Inc. Wins “Dallas A-List” Award for Best Pet Sitting Company in North Texas
7. Survey by Dissertation-Texas Reveals Exceptional Rise in Research Projects
8. Marco Cervantes - State Farm Insurance Agent Opens Doors in Katy, Texas
9. The Texas Thyroid Institute is Now Testing for Food Sensitivities
10. 2013 Best Security System Companies in San Antonio, Texas According to 6Webs.com
11. "Little" 9/11 Museum in NYC Gets Some "Big" Love from Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... A four alarm fire ... site and threatened numerous homes and businesses nearby, causing some 700 individuals to ... Los Angeles Area consulting firm Fire Protection Group, Inc. notes that the report ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... initiatives designed to promote awareness for Topricin’s revolutionary, natural, after-burn skin care product, ... of the leading causes of long term skin conditions, including cancer. In ...
(Date:7/24/2017)... ... July 24, 2017 , ... The 2017 ... MD. This year's theme focuses on the new ISO/IEC 17025 standards. This marks ... integrity in testing and calibration will be changed. , As an exhibitor, ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... received the prestigious StorErotica “Consumer’s Choice” Award, for favorite sex toy. Created in ... 11th annual StorErotica Awards to be consumer voted. The Magic Wand Rechargeable won ...
(Date:7/24/2017)... , ... July 24, 2017 , ... ... Medicine Clinical Vitiligo Hospital" was set up, and the awarding ceremony was held ... Chinese medicine, the head of the army's health system, and national Chinese medicine ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)...  Centurion Medical Products, a leader in medical product innovation and ... removal device for hospice patient care. ... Centurion Medical Products ... Patient pain management and emotional comfort are part of a ... pain while preventing unneeded emergency department admission due to severe fecal ...
(Date:7/11/2017)... July 11, 2017 Zymo Research Corp., also known as ,The ... quantify biological aging in a precise manner using the myDNAge ™ ... , a professor of human genetics and biostatistics at the David ... Public Health , Zymo Research,s proprietary DNAge ™ technology is used ... ...
(Date:7/11/2017)... 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, ... (FDA) has agreed to schedule an End-of-Phase II meeting ... of its oral insulin capsule ORMD-0801 in the treatment ... primary and secondary endpoints by indicating a statistically significant ...
Breaking Medicine Technology: